CHAMP-UK

Low-dose atropine eye drops to reduce progression of myopia in children: a multi-centre placebo controlled randomised trial in the United Kingdom

[Emma McConnell @19EmmaM]

We recruited our last participant to the CHAMP-UK low dose atropine for myopia trial at the @NICRFqub today! 🥳 This study is investigating the efficacy of 0.01% atropine to slow the progression of myopia in children living in the UK. Follow along for more updates: @uk_champ 👀

[Michael Williams @Mike_W_Eyes]

⁦@QUBelfast⁩ ⁦@QUBMedEd⁩ ⁦@QUBMediaLab⁩ @RCOphth⁩ ⁦@QUBGPSociety⁩ Welcome to a new podcast! For Med students, & others, & it’s on ophthalmology. We cover amaurosis fugax in episode 1. Enjoy, please share! https://t.co/B4zUpk8X4h

[NICRF @NICRFqub]

Work with us! We're hiring a Clinical Trials Assistant with a focus on ophthalmology. https://t.co/hLOkkSO5NA

[Emma McConnell @19EmmaM]

Let's do this! 💪🏻🏅

[Nicola Logan @_NicolaLogan]

Myopia clinic @AstonOptometry is one of the recruiting sites. Recruiting children aged 6 to 12 years with myopia #children #myopia #atropine #MyopiaManagement #Birmingham

[CHAMP-UK @uk_champ]

The CHAMP-UK Trial requires just 50 further participants in order to meet our recruitment target. Thank-you to all our incredible sites for their efforts. One last push required now to get over the line!

[@OptometryToday @OptometryToday]

Congrats to all involved. 👏 The CHAMP-UK study is investigating the efficacy of low dose atropine on the progression of myopia in children. Great work @19EmmaM @AAzuaraBlanco @NICRFqub. Read more about the study in the link below. #OT

[GCU Vision Sciences @GCUVisSci]

Myopia trial: We are still recruiting short-sighted children to take part in the CHAMP-UK trial investigating the use of low dose atropine eye-drops to slow myopia progression. We are looking for children aged 6-12 years with healthy eyes. Contact: [email protected]

[GCU Vision Sciences @GCUVisSci]

*Please Share*
We are seeking short-sighted children to take part in CHAMP-UK, a multi-centre trial investigating whether using low dose atropine eye drops can slow the progression of myopia (short-sightedness).
Follow the link for more information: https://t.co/tw3hUv1MSF

[NICRF @NICRFqub]

Last week we had the 100th participant to the Champ study - looking at myopia in children. Well done @19EmmaM and @AAzuaraBlanco

https://t.co/p6L0OrIIxl

[Emma McConnell @19EmmaM]

Delighted to welcome our 100th wonderful participant onto the @uk_champ trial at the @NICRFqub last week! CHAMP-UK is investigating the efficacy of low dose atropine on the progression of myopia in children. 🤓 See more via the link below 👇

[CHAMP-UK @uk_champ]

We are delighted to have @AstonUniversity / @Bham_Childrens come on-board the CHAMP-UK trial. We look forward to working with them going forward.

[NES Optometry @NESOptometry]

Join our Myopia Control webinar, 12th May 7.30-8.30pm. Learn about #myopia progression, evidence-based myopia management & the #CHAMPUK clinical trial. 1 interactive CET point for OO, DO & CLO. Book: https://t.co/oxViBCuLU5
#NESOptometry #EvidenceBasedPractice @uk_champ

[Ophthalmology at BMJ @BMJ_Ophth]

The Childhood Atropine for Myopia Progression in the UK #CHAMPUK study is the first randomised trial reporting outcomes of low-dose atropine eye-drops 0.01% for potentially reducing #myopia progression in children. Read more for the study protocol. https://t.co/aTh1Gt3CGY

[Moorfields Eye Hospital NHS Foundation Trust @Moorfields]

We know some patients are worried about coming in for appointments or treatment, but we want to reassure you that we have safety measures in place to help keep you safe. Don't delay - your sight matters.

[CHAMP-UK @uk_champ]

CHAMP-UK: Low-dose atropine eye drops to reduce progression of short-sightedness (myopia) in children in the United Kingdom https://t.co/bD10m7P9G0 #ISRCTN

[CHAMP-UK @uk_champ]

CHAMP-UK is now open to recruitment! Well done to the team at Belfast who have recruited 9 participants to date. We look forward at opening at our remaining sites throughout the UK very soon. #CHAMPUK

[ISRCTN: the UK's Clinical Study Registry @ISRCTN]

Can eye drops stop children from getting more #shortsighted with age? CHAMP UK: a newly registered #ISRCTN trial by @BelfastTrust @The_MRC @OfficialNIHR @CPH_QUB @Paul_Doherty__

https://t.co/cIkWW5QF8f

#clinicaltrials #paediatrics #Ophthalmology #eyehealth